Squarepoint’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,072
| Closed | -$28.7K | – | 3032 |
|
|
2023
Q4 | $28.7K | Buy |
+1,072
| New | +$28.7K | ﹤0.01% | 2408 |
|
|
2023
Q2 | – | Sell |
-5,439
| Closed | -$961K | – | 2924 |
|
|
2023
Q1 | $961K | Buy |
+5,439
| New | +$961K | ﹤0.01% | 1185 |
|
|
2022
Q3 | – | Sell |
-728
| Closed | -$239K | – | 2616 |
|
|
2022
Q2 | $239K | Buy |
+728
| New | +$239K | ﹤0.01% | 1658 |
|
|
2022
Q1 | – | Sell |
-401
| Closed | -$176K | – | 2926 |
|
|
2021
Q4 | $176K | Buy |
401
+40
| +11% | +$17.6K | ﹤0.01% | 2147 |
|
|
2021
Q3 | $201K | Buy |
+361
| New | +$201K | ﹤0.01% | 1826 |
|
|
2021
Q2 | – | Sell |
-296
| Closed | -$232K | – | 3112 |
|
|
2021
Q1 | $232K | Buy |
+296
| New | +$232K | ﹤0.01% | 2071 |
|
|
2020
Q4 | – | Sell |
-868
| Closed | -$397K | – | 2938 |
|
|
2020
Q3 | $397K | Buy |
+868
| New | +$397K | 0.01% | 1509 |
|
|
2020
Q2 | – | Sell |
-311
| Closed | -$148K | – | 2490 |
|
|
2020
Q1 | $148K | Sell |
311
-863
| -74% | -$411K | ﹤0.01% | 1552 |
|
|
2019
Q4 | $681K | Buy |
1,174
+885
| +306% | +$513K | ﹤0.01% | 1546 |
|
|
2019
Q3 | $190K | Buy |
+289
| New | +$190K | ﹤0.01% | 1994 |
|
|
2018
Q4 | – | Sell |
-272
| Closed | -$235K | – | 2276 |
|
|
2018
Q3 | $235K | Buy |
+272
| New | +$235K | ﹤0.01% | 1671 |
|
|
2018
Q1 | – | Sell |
-2,460
| Closed | -$1.08M | – | 2213 |
|
|
2017
Q4 | $1.08M | Buy |
+2,460
| New | +$1.08M | 0.02% | 783 |
|
|
2017
Q1 | – | Sell |
-2,452
| Closed | -$820K | – | 1952 |
|
|
2016
Q4 | $820K | Buy |
+2,452
| New | +$820K | 0.03% | 583 |
|